Covered recipient · General Payments record
KALLAN MONTGOMERY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$456.33
- Reported across 21 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $312.66 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $68.12 | 3 |
| Novo Nordisk AS | $62.07 | 3 |
| PFIZER INC. | $37.76 | 2 |
| Lilly USA, LLC | $29.61 | 2 |
| Exact Sciences Corporation | $28.01 | 2 |
| Radius Health, Inc. | $23.72 | 1 |
| Astellas Pharma US Inc | $23.25 | 1 |
| DEXCOM, INC. | $22.05 | 1 |
| Phathom Pharmaceuticals, Inc. | $18.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.01 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105057682 | CMS |
| ABBVIE INC. | $20.36 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105057684 | CMS |
| ABBVIE INC. | $16.75 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105057686 | CMS |
| Astellas Pharma US Inc | $23.25 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139314360 | CMS |
| Dexcom, Inc. | $22.05 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153312628 | CMS |
| Exact Sciences Corporation | $14.34 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114794806 | CMS |
| Exact Sciences Corporation | $13.67 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114794811 | CMS |
| Lilly USA, LLC | $13.93 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135105215 | CMS |
| Lilly USA, LLC | $15.68 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135117255 | CMS |
| Novo Nordisk Inc | $24.06 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096660136 | CMS |
| Novo Nordisk Inc | $24.65 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096897829 | CMS |
| Novo Nordisk Inc | $13.36 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096950150 | CMS |
| PFIZER INC. | $14.61 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131687604 | CMS |
| PFIZER INC. | $23.15 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132107252 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.07 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151098337 | CMS |
| Radius Health, Inc. | $23.72 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089964923 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.